Immune response to HHV-6 and implications for immunotherapy

Area of Science:

• Virology
• Immunology
• Transplantation Medicine

Background:

• Most adults harbor latent human herpesvirus 6 (HHV-6), typically controlled by the immune system after childhood infection.
• Immunosuppression following solid organ transplantation (SOT) or hematopoietic stem cell transplantation (HSCT) can lead to HHV-6 reactivation.
• Reactivated HHV-6 is linked to adverse outcomes, including graft rejection and neurological issues in transplant recipients.

Purpose of the Study:

• To investigate the T cell response against HHV-6 antigens in chronically infected adults.
• To explore the potential of T cell-based immunotherapy for managing post-transplantation HHV-6 reactivation.

Main Methods:

• Identification of HHV-6 antigens recognized by CD4+ and CD8+ T cells in chronically infected individuals.
• In vitro expansion of T cell populations targeting identified HHV-6 antigens.

Main Results:

• Specific HHV-6 antigens have been identified as targets of the adaptive immune response.
• T cell populations capable of recognizing these antigens can be successfully expanded ex vivo.

Conclusions:

• The findings highlight a potential immunotherapeutic strategy for controlling HHV-6 reactivation after transplantation.
• Autologous T cell therapy targeting specific HHV-6 antigens shows promise for improving transplant outcomes.